Tag: ovarianCancer
Articles
News
Foods
Studies
- A Prospective Study on Dietary Acrylamide Intake and the Risk for Breast, Endometrial, and Ovarian Cancers
- A two-step screening method, using estrogen receptor-mediated transactivation, to measure estrogenicity in edible plants
- ABO blood group and incidence of epithelial ovarian cancer
- Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
- Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells
- Anti-cancer activity of the bioactive compound inositol pentakisphosphate
- Antibiotic use predicts an increased risk of cancer
- Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
- Breast and Ovarian Cancer in Relatives of Cancer Patients, with and without BRCA Mutations
- Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
- Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
- Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
- Cancer incidence in British vegetarians
- Cancer morbidity in a cohort of 9175 Finnish women treated for infertility
- Cisplatin combination with allyl isothiocyanate, a constituent of cruciferous vegetables, synergistically increases cancer cell death through activation of caspase 3 and downregulation of the antiapoptotic protein Bcl-2 and survivin
- Clustering dietary habits and the risk of breast and ovarian cancers
- Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
- Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin
- Cruciferous vegetables and cancer risk in a network of case-control studies
- Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort
- Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis
- Dietary intake and breast density in high-risk women: a cross-sectional study
- Dietary transfatty acids and cancer risk
- Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
- Increased Rates of Chromosome Breakage in BRCA1 Carriers Are Normalized by Oral Selenium Supplementation
- Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan
- Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects
- Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort
- Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study
- Onion and garlic use and human cancer
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis
- Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis
- Ovarian metastases from breast cancer: report of 29 cases
- Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis
- Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
- Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
- Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age